Skip to main content
. Author manuscript; available in PMC: 2017 Jul 1.
Published in final edited form as: Stroke. 2016 Jun 7;47(7):1782–1788. doi: 10.1161/STROKEAHA.116.013320

Table 1.

Clinical characteristics.

Final Diagnosis
Variable All (N=21) ICAD (N=10) MMD (N=8) V (N=3)
Age – years 41 ± 14 49 ± 14 35 ± 11 30 ± 3
Gender Male 3 (14.3) 1 (10.0) 2 (25.0) 0 (0.0)
Female 18 (85.7) 9 (90.0) 6 (75.0) 3 (100.0)
Race Caucasian 10 (47.6) 4 (40.0) 5 (62.5) 1 (33.3)
Asian 1 (4.8) 1 (10.0) 0 (0.0) 0 (0.0)
Hispanic 9 (42.9) 4 (40.0) 3 (37.5) 2 (66.7)
Black 1 (4.8) 1 (10.0) 0 (0.0) 0 (0.0)
Risk factors Hypertension 8 (38.1) 8 (80.0) 0 (0.0) 0 (0.0)
Hyperlipidemia 9 (42.9) 8 (80.0) 1 (12.5) 0 (0.0)
Diabetes 7 (33.3) 6 (60.0) 1 (12.5) 0 (0.0)
Obesity* 8 (38.1) 6 (60.0) 2 (25.0) 0 (0.0)
Current smoker 1 (4.8) 1 (10.0) 0 (0.0) 0 (0.0)
Coronary artery disease 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0)
No. of risk factors 0 7 (33.3) 0 (0.0) 4 (50.0) 3 (100.0)
1 4 (19.1) 0 (0.0) 4 (50.0) 0 (0.0)
2-4 10 (47.6) 10 (100.0) 0 (0.0) 0 (0.0)
Luminal Imaging DSA 13 (61.9) 5 (50.0) 8 (100.0) 0 (0.0)
CTA 15 (71.4) 8 (80.0) 6 (75.0) 1 (33.3)
MRA 21 (100.0) 10 (100.0) 8 (100.0) 3 (100.0)

Values are mean ± SD or no. (%);

ICAD = intracranial atherosclerotic disease; MMD = moyamoya disease; V = vasculitis;

*

Body mass index > 30 kg/m2.